Description
Docopa 400 mg is a bronchodilator containing Doxofylline, a methylxanthine derivative. It is structurally related to theophylline but has a better safety profile due to its selective inhibition of phosphodiesterase-4 (PDE4) and lower affinity for adenosine receptors. This leads to relaxation of bronchial smooth muscles, making it effective in managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD).
 1000 MG.jpg)
.jpeg)
 4ML.jpg)
.jpeg)
.webp)
.webp)
.webp)
Change Language